United Kingdom pharmaceutical
market is expected to register robust growth in the forecast period, 2023-2027.
Innovations in the fields of oncology, autoimmune, and diabetes treatment will
continue to augment the United Kingdom pharmaceutical market. Emerging markets
will see a steady rise is people seeking treatment for these diseases owing to
the advancements in treatments and prevention will continue to propel the
market growth. Growing number of patients who experience chronic ailments or
pain which drives the market growth. In addition to this, chronic illness
including hypertension and mental health issues are key driver of the growth in
pharmaceutical market in United Kingdom. The pharmaceuticals that treat rare
diseases as advancements in pharmaceuticals offer numerous solutions and
up-gradations in medicine uncover more problems.
The Expanding Geriatric
Population is Projected to Fuel the Market Growth
Chronic conditions are
on the rise and patients are often suffering from more than just one ailment.
This development is intensified owing to the growing middle-class and
escalating adoption of sedentary lifestyles in emerging markets, which results
into obesity, diabetes, and other costly health conditions. Chronic
noncommunicable disease prevalence such as cardiovascular diseases or cancer
are accelerating the demand for pharmaceuticals. The increasing elderly
population and the high requirement of more medical care especially to older
population are driving the growth of the pharmaceutical market. Government
health programs including Medicaid and Medicare enable a wider range of seniors
to be covered. Additionally, advancements in healthcare that people are living
longer and requiring services for a longer period.
Growing Number of
Chronic Diseases is Expected to Bolster the Market Growth
The escalating demand
for healthcare and innovative solutions is one of the primary factors
propelling the market growth. Digitalization, big data and artificial
intelligence drives the transformation of the pharmaceutical sector and allow
companies to enhance drug development and patient care beyond the treatment of
diseases, which provide a new revenue stream. For patient care, digital
solutions allow the shift from a disease focus to an integrated approach from
prevention, screening, diagnostic, treatment, and aftercare. Continuous
technological advancement and novel therapeutic approaches have the potential
to not only treat, but also assist in curing diseases – or identifying and
eliminating risk factors before a disease develops. Part of this development
are personalized therapies, a promising approach tailoring medical treatment to
the individual characteristics of each patient. The emerging associations between
the human microbiome, health and disease are leading to novel diagnostics and
therapeutics thereby improving personalized medicine. All these aforementioned factors are expected
to augment the pharmaceutical market across United Kingdom during the forecast
years.
DOWNLOAD FREE SAMPLE REPORT
Market Segmentation
The United Kingdom Pharmaceutical
market is segmented into drug type, product type, application, distribution channel, regional distribution, and competitive
landscape. Based on drug type, the market is bifurcated into generic drugs and
branded drugs. Based on product type, the market is divided into prescription
drugs and over-the-counter drugs. Based on application, the market is segmented
into cardiovascular, musculoskeletal, oncology, anti-infective, metabolic
disorder, others. Based on end user, the market is divided into retail pharmacy, hospital
pharmacy, e-pharmacy. The United Kingdom pharmaceutical market
is studied in major regions namely London, Southeast, East Anglia, Scotland,
Southwest, East Midlands, Yorkshire & Humberside, Rest of United Kingdom.
Market Players
Takeda Pharmaceutical Company
Limited, GlaxoSmithKline Plc., Vertex Pharmaceuticals (U.K.) Limited, Pfizer
Limited, Novartis UK Limited, AstraZeneca UK Limited, Bristol-Myers Squibb
Pharmaceuticals Limited, Roche Products Limited, Sanofi UK, Sun Pharmaceuticals
UK Limited are the key market players operating in United Kingdom Pharmaceutical
market.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historic Data
|
2017 – 2020
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023 – 2027
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
|
|
Report coverage
|
Revenue forecast, company share, competitive landscape, growth
factors, and trends
|
|
Segments covered
|
·
Drug Type
·
Product Type
·
Application
·
Distribution
Channel
|
|
Regional scope
|
London, Southeast, East Anglia, Scotland, Southwest, East
Midlands, Yorkshire & Humberside, Rest of United Kingdom
|
|
Key companies profiled
|
Takeda Pharmaceutical Company Limited,
GlaxoSmithKline Plc., Vertex Pharmaceuticals (U.K.) Limited, Pfizer Limited,
Novartis UK Limited, AstraZeneca UK Limited, Bristol-Myers Squibb
Pharmaceuticals Limited, Roche Products Limited, Sanofi UK, Sun
Pharmaceuticals UK Limited
|
|
Customization scope
|
10% free report customization with purchase. Addition or
alteration to regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also provide the editable version
of the report in PPT/Word format on special request)
|
Report Scope:
In this report, United Kingdom Pharmaceutical
market has been segmented into following categories, in addition to the
industry trends which have also been detailed below:
·
United Kingdom Pharmaceutical
Market, By Drug Type:
o Generic Drugs
o Branded Drugs
·
United Kingdom
Pharmaceutical Market, By Product Type:
o Prescription Drugs
o Over-The-Counter Drugs
·
United Kingdom Pharmaceutical
Market, By Application:
o Cardiovascular
o Musculoskeletal
o Oncology
o Anti-infective
o Metabolic Disorder
o
Others
·
United Kingdom Pharmaceutical
Market, By Distribution Channel:
o Retail Pharmacy
o Hospital Pharmacy
o E-Pharmacy
·
United Kingdom Pharmaceutical
Market, By Region:
o
London
o
Southeast
o
East
Anglia
o
Scotland
o
Southwest
o
East
Midlands
o
Yorkshire
& Humberside
o
Rest
of United Kingdom
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in United Kingdom Pharmaceutical market.
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
o Detailed analysis and profiling of
additional market players (up to five).
United Kingdom pharmaceutical
market is an upcoming report to be released soon. If you wish an early
delivery of this report or want to confirm the date of release, please contact
us at [email protected]